{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T10:44:46Z","timestamp":1790246686547,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["atherosclerosis-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.atherosclerosis.2013.02.023","type":"journal-article","created":{"date-parts":[[2013,2,28]],"date-time":"2013-02-28T19:42:40Z","timestamp":1362080560000},"page":"69-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Beneficial effects of quinoline-3-carboxamide (ABR-215757) on atherosclerotic plaque morphology in S100A12 transgenic ApoE null\u00a0mice"],"prefix":"10.1016","volume":"228","author":[{"given":"Ling","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Bjork","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radu","family":"Butuc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Gawdzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Earley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion A.","family":"Hofmann Bowman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2013.02.023_bib1","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1161\/CIRCRESAHA.109.212217","article-title":"The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature","volume":"106","author":"Yan","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2013.02.023_bib2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1161\/ATVBAHA.111.236927","article-title":"S100A8 and S100A9 in cardiovascular biology and disease","volume":"32","author":"Averill","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2013.02.023_bib3","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0092-8674(00)80801-6","article-title":"RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100\/calgranulin polypeptides","volume":"97","author":"Hofmann","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.atherosclerosis.2013.02.023_bib4","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/nm1638","article-title":"Mrp8 and Mrp14 are endogenous activators of toll-like receptor 4, promoting lethal, endotoxin-induced shock","volume":"13","author":"Vogl","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.atherosclerosis.2013.02.023_bib5","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7326\/0003-4819-153-7-201010050-00005","article-title":"Multicenter validation of the diagnostic accuracy of a blood-based gene expression test for assessing obstructive coronary artery disease in nondiabetic patients","volume":"153","author":"Rosenberg","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.atherosclerosis.2013.02.023_bib6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1161\/CIRCGENETICS.108.782730","article-title":"Correlation of peripheral-blood gene expression with the extent of coronary artery stenosis","volume":"1","author":"Wingrove","year":"2008","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.atherosclerosis.2013.02.023_bib7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ahj.2007.08.018","article-title":"Myeloid-related protein 8\/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the pravastatin or atorvastatin evaluation and infection therapy: thrombolysis in myocardial infarction (PROVE IT-TIMI 22) trial","volume":"155","author":"Morrow","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.atherosclerosis.2013.02.023_bib8","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1093\/eurheartj\/ehm078","article-title":"Myeloid-related protein 8\/14 complex is released by monocytes and granulocytes at the site of coronary occlusion: a novel, early, and sensitive marker of acute coronary syndromes","volume":"28","author":"Altwegg","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2013.02.023_bib9","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1161\/01.ATV.0000131783.74034.97","article-title":"Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study","volume":"24","author":"Burke","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2013.02.023_bib10","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1161\/STROKEAHA.111.642256","article-title":"High levels of S100A12 are associated with recent plaque symptomatology in patients with carotid atherosclerosis","volume":"43","author":"Abbas","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2013.02.023_bib11","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jacc.2012.04.027","article-title":"S100A12 expression in thoracic aortic aneurysm is associated with increased risk of dissection and perioperative complications","volume":"60","author":"Das","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2013.02.023_bib12","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/ATVBAHA.110.217745","article-title":"S100A12 in vascular smooth muscle accelerates vascular calcification in apolipoprotein E-null mice by activating an osteogenic gene regulatory program","volume":"31","author":"Hofmann Bowman","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2013.02.023_bib13","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1371\/journal.pbio.1000097","article-title":"Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides","volume":"7","author":"Bjork","year":"2009","journal-title":"PLoS Biol"},{"key":"10.1016\/j.atherosclerosis.2013.02.023_bib14","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1002\/art.33493","article-title":"Pharmacokinetics, tolerability, and preliminary efficacy of ABR-215757, a new quinoline-3-carboxamide derivative, in murine and human SLE","volume":"64","author":"Bengtsson","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.atherosclerosis.2013.02.023_bib15","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.intimp.2004.07.009","article-title":"The impact of a new immunomodulator oxo-quinoline-3-carboxamide on the progression of experimental lupus","volume":"4","author":"Carlsten","year":"2004","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.atherosclerosis.2013.02.023_bib16","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1056\/NEJMoa1104318","article-title":"Placebo-controlled trial of oral laquinimod for multiple sclerosis","volume":"366","author":"Comi","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2013.02.023_bib17","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1002\/art.20631","article-title":"Proinflammatory S100 proteins in arthritis and autoimmune disease","volume":"50","author":"Foell","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.atherosclerosis.2013.02.023_bib18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1161\/CIRCRESAHA.109.209486","article-title":"S100A12 mediates aortic wall remodeling and aortic aneurysm","volume":"106","author":"Hofmann Bowman","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2013.02.023_bib19","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1089\/omi.2004.8.334","article-title":"Computational searches for missing orthologs: the case of S100A12 in mice","volume":"8","author":"Fuellen","year":"2004","journal-title":"OMICS"},{"key":"10.1016\/j.atherosclerosis.2013.02.023_bib20","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1189\/jlb.69.6.986","article-title":"Proinflammatory properties of the human S100 protein S100A12","volume":"69","author":"Yang","year":"2001","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.atherosclerosis.2013.02.023_bib21","doi-asserted-by":"crossref","first-page":"e34698","DOI":"10.1371\/journal.pone.0034698","article-title":"RAGE expression in human t cells: a link between environmental factors and adaptive immune responses","volume":"7","author":"Akirav","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2013.02.023_bib22","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1172\/JCI32703","article-title":"Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-\/- mice","volume":"118","author":"Harja","year":"2008","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2013.02.023_bib23","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/S0140-6736(02)11683-7","article-title":"Hyperzincaemia and hypercalprotectinaemia: a new disorder of zinc metabolism","volume":"360","author":"Sampson","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2013.02.023_bib24","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1161\/CIRCULATIONAHA.108.814582","article-title":"Myeloid-related protein-8\/14 is critical for the biological response to vascular injury","volume":"120","author":"Croce","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.02.023_bib25","doi-asserted-by":"crossref","unstructured":"Maiseyeu A, Badgeley MA, Kampfrath T, et\u00a0al. In\u00a0vivo targeting of inflammation-associated myeloid-related protein 8\/14 via gadolinium immunonanoparticles. Arterioscler Thromb Vasc Biol;32:962\u201370.","DOI":"10.1161\/ATVBAHA.111.244509"},{"key":"10.1016\/j.atherosclerosis.2013.02.023_bib26","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1172\/JCI43713","article-title":"Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice","volume":"122","author":"Alexander","year":"2012","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2013.02.023_bib27","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.bmcl.2009.01.045","article-title":"Quinolines as a novel structural class of potent and selective PDE4 inhibitors: optimisation for oral administration","volume":"19","author":"Lunniss","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.atherosclerosis.2013.02.023_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2010.08.054","article-title":"Synthesis, biological assessment and molecular modeling of new dihydroquinoline-3-carboxamides and dihydroquinoline-3-carbohydrazide derivatives as cholinesterase inhibitors, and Ca channel antagonists","volume":"46","author":"Tomassoli","year":"2011","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.atherosclerosis.2013.02.023_bib29","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/096120339300200108","article-title":"Calprotectin in patients with systemic lupus erythematosus: relation to clinical and laboratory parameters of disease activity","volume":"2","author":"Haga","year":"1993","journal-title":"Lupus"},{"key":"10.1016\/j.atherosclerosis.2013.02.023_bib30","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.3899\/jrheum.081302","article-title":"Phagocyte-specific S100A8\/A9 protein levels during disease exacerbations and infections in systemic lupus erythematosus","volume":"36","author":"Soyfoo","year":"2009","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.atherosclerosis.2013.02.023_bib31","doi-asserted-by":"crossref","unstructured":"Lood C, Stenstrom M, Tyden H, et\u00a0al. Protein synthesis of the pro-inflammatory S100A8\/A9 complex in plasmacytoid dendritic cells and cell surface S100A8\/A9 on leukocyte subpopulations in systemic lupus erythematosus. Arthritis Res Ther;13:R60.","DOI":"10.1186\/ar3314"},{"key":"10.1016\/j.atherosclerosis.2013.02.023_bib32","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1084\/jem.20080132","article-title":"Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein","volume":"205","author":"Cheng","year":"2008","journal-title":"J\u00a0Exp Med"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915013001330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915013001330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T20:30:48Z","timestamp":1688070648000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915013001330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0021915013001330"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.02.023","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beneficial effects of quinoline-3-carboxamide (ABR-215757) on atherosclerotic plaque morphology in S100A12 transgenic ApoE null\u00a0mice","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.02.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}